Real-World Treatment Patterns and Outcomes Among Patients With Chronic Myeloid Leukemia in Earlier Lines of Therapy
Clinical trial NCT06692803 · COMPLETED
Trial details
- NCT number
- NCT06692803
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-05-23
- Primary completion
- 2023-11-30
- Enrollment
- 2043
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.